[Angiocardioscintigraphy in the cardiological surveillance of chemotherapy with anthracyclines].
Equilibrium angiocardioscintigraphy is a noninvasive nuclear medical method which allows cardiac function to be assessed. It is widely used in oncology since some clinically important drugs used in antitumor chemotherapy have a marked cardiotoxic effect. Angiocardioscintigraphy enables several parameters characteristic of cardiac function to be assessed, namely the left ventricular ejection fraction whose alterations during chemotherapy allow possible cardiotoxic side effects to be revealed before the development of irreversible heart failure.
Crippa
F
F
Divisione di Medicina Nucleare, Istituto Nazionale Tumori, Milano.
Bombardieri
E
E
Villani
F
F
Buraggi
G L
GL
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D015637:Gated Blood-Pool Imaging / Q000379:methods*; D006321:Heart / Q000000981:diagnostic imaging* / Q000187:drug effects; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods; D011875:Radionuclide Angiography / Q000379:methods; D013318:Stroke Volume; D013667:Technetium
D000903:Antibiotics, Antineoplastic; D013667:Technetium
La angiocardioscintigrafia nella sorveglianza cardiologica della chemioterapia con antracicline.